Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinitis pigmentosain which the cause of the disease is a variation in the RDS gene (PRPH2). A digenic form of retinitis pigmentosa, resulting from a mutation in the RDS gene and a null mutation of the ROM1 gene, has also been reported.
Features include sometimes findings: Chorioretinal atrophy. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Pigmentary retinopathy, Adult-onset night blindness, Attenuation of retinal blood vessels |
Muscles |
PRPH2 function has not been fully characterized.
Retinitis pigmentosa 7 is associated with mutations in the PRPH2 gene on chromosome 6.
ROM1 function has not been fully characterized.
Retinitis pigmentosa 7 is associated with mutations in the ROM1 gene on chromosome 11.
Genetic testing for PRPH2, ROM1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 7 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 7.
50 publications have been identified in PubMed for retinitis pigmentosa 7. Research spans Basic Science / Preclinical (36%), Epidemiology / Natural History (26%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 18 | 36% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:32 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Chorioretinal atrophy |
Age of onset: adulthood.
13 |
26% |
Patient case studies | 9 | 18% |
Research summaries | 3 | 6% |
New treatment approaches | 3 | 6% |
Testing and diagnosis research | 2 | 4% |
Clinical study results | 2 | 4% |
Chattannavar G (2026). [PMID: 42161901](https://pubmed.ncbi.nlm.nih.gov/42161901/). *Ophthalmic Genet*. [Case Report / Case Series]
Abu Serhan H (2026). [PMID: 41721385](https://pubmed.ncbi.nlm.nih.gov/41721385/). *Int J Retina Vitreous*. [Review / Meta-Analysis]
Krumpoeck PE (2026). [PMID: 42020935](https://pubmed.ncbi.nlm.nih.gov/42020935/). *Ear Hear*. [Epidemiology / Natural History]
Appelbaum T (2026). [PMID: 41649227](https://pubmed.ncbi.nlm.nih.gov/41649227/). *Investigative ophthalmology & visual science*. [Case Report / Case Series]
Shan T (2026). [PMID: 42194986](https://pubmed.ncbi.nlm.nih.gov/42194986/). *Genes (Basel)*. [Epidemiology / Natural History]
Hühne T (2026). [PMID: 40903014](https://pubmed.ncbi.nlm.nih.gov/40903014/). *The Journal of clinical endocrinology and metabolism*. [Basic Science / Preclinical]
Milheiro J (2026). [PMID: 41940113](https://pubmed.ncbi.nlm.nih.gov/41940113/). *Clin Nephrol Case Stud*. [Case Report / Case Series]
Merolla L (2026). [PMID: 41982462](https://pubmed.ncbi.nlm.nih.gov/41982462/). *Mol Vis*. [Basic Science / Preclinical]
Xia XX (2026). [PMID: 41763034](https://pubmed.ncbi.nlm.nih.gov/41763034/). *Stem cell research*. [Gene Therapy / Novel Therapeutics]
Hazelwood JE (2026). [PMID: 41514076](https://pubmed.ncbi.nlm.nih.gov/41514076/). *Eye (London, England)*. [Epidemiology / Natural History]